UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

A Novel CACNA1F Gene Mutation Causes Aland Island Eye Disease

Investigative ophthalmology & visual science, 2007-06, Vol.48 (6), p.2498-2502

2007

Volltextzugriff (PDF)

Alternative splice variants of the USH3A gene Clarin 1 (CLRN1)

European journal of human genetics : EJHG, 2011-01, Vol.19 (1), p.30-35

2011

Volltextzugriff (PDF)

Extended mutation spectrum of Usher syndrome in Finland

Acta ophthalmologica (Oxford, England), 2013-06, Vol.91 (4), p.325-334

2013

Volltextzugriff (PDF)

Genetic background of HSH in three Polish families and a patient with an X;9 translocation

European journal of human genetics : EJHG, 2006-01, Vol.14 (1), p.55-62

2006

Volltextzugriff (PDF)

Interstitial 1q25.3‐q31.3 deletion in a boy with mild manifestations

American journal of medical genetics, 2003-12, Vol.123A (3), p.290-295

2003

Volltextzugriff (PDF)

A Novel CACNA1F Gene Mutation Causes Åland Island Eye Disease

Investigative ophthalmology & visual science, 2007-06, Vol.48 (6), p.2498

2007

Volltextzugriff (PDF)

Interstitial 1q25.3-q31.3 deletion in a boy with mild manifestations

American Journal of Medical Genetics Part A, 2003, Vol.123A (3), p.290-295

2003

Volltextzugriff (PDF)

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8 + T-cell Response against Immunosuppressive Tumors

Clinical cancer research, 2019-06, Vol.25 (11), p.3289-3303

2019

Volltextzugriff (PDF)

Lymphatic Endothelial Cell Activation and Dendritic Cell Transmigration Is Modified by Genetic Deletion of Clever-1

Frontiers in immunology, 2021-03, Vol.12, p.602122-602122

2021

Volltextzugriff (PDF)

Abstract 4744: Disruption of Clever-1 in macrophages activates the innate immune response and mediates tumor rejection

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4744-4744

2018

Volltextzugriff (PDF)

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial

Clinical cancer research, 2021-08, Vol.27 (15), p.4205-4220

2021

Volltextzugriff (PDF)

Abstract 4740: CLEVER-1 as a marker to identify breast cancer patients under immunosuppression

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4740-4740

2018

Volltextzugriff (PDF)

Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice

Frontiers in immunology, 2018-10, Vol.9, p.2257-2257

2018

Volltextzugriff (PDF)

Immune activation in first-in-human anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) phase I/II MATINS trial: Part I dose-escalation, safety, and efficacy results

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3097-3097

2020

Volltextzugriff (PDF)

Abstract 2269: Bexmarilimab induces B-cell activation and autoantibody production

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2269-2269

2023

Volltextzugriff (PDF)

Clever-1 contributes to lymphocyte entry into the spleen via the red pulp

Science immunology, 2019-03, Vol.4 (33)

2019

Volltextzugriff (PDF)

Postnatal development and LPS responsiveness of pulmonary adenosine receptor expression and of adenosine-metabolizing enzymes in mice

Pediatric research, 2014-12, Vol.76 (6), p.515-521

2014

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)
Berichte
(1)

Sprache

Englisch
(17)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Humans
(7)
Male
(5)
Biological And Medical Sciences
(4)
Female
(4)
Mutation
(4)
Animals
(3)
Genetics & Heredity
(3)
Immunology
(3)
Medical Genetics
(3)
Medical Sciences
(3)
Ophthalmology
(3)
Pedigree
(3)
1q25.3-Q31.3
(2)
Biochemistry & Molecular Biology
(2)
Cd8-Positive T-Lymphocytes - Immunology
(2)
Chromosome 1
(2)
Chromosome Aberrations
(2)
Dna Mutational Analysis
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Novel CACNA1F Gene Mutation Causes Aland Island Eye Disease

Alternative splice variants of the USH3A gene Clarin 1 (CLRN1)

Extended mutation spectrum of Usher syndrome in Finland

Genetic background of HSH in three Polish families and a patient with an X;9 translocation

Interstitial 1q25.3‐q31.3 deletion in a boy with mild manifestations

A Novel CACNA1F Gene Mutation Causes Åland Island Eye Disease

Interstitial 1q25.3-q31.3 deletion in a boy with mild manifestations

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8 + T-cell Response against Immunosuppressive Tumors

Lymphatic Endothelial Cell Activation and Dendritic Cell Transmigration Is Modified by Genetic Deletion of Clever-1

Abstract 4744: Disruption of Clever-1 in macrophages activates the innate immune response and mediates tumor rejection

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial

Abstract 4740: CLEVER-1 as a marker to identify breast cancer patients under immunosuppression

Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice

Immune activation in first-in-human anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) phase I/II MATINS trial: Part I dose-escalation, safety, and efficacy results

Abstract 2269: Bexmarilimab induces B-cell activation and autoantibody production

Clever-1 contributes to lymphocyte entry into the spleen via the red pulp

Postnatal development and LPS responsiveness of pulmonary adenosine receptor expression and of adenosine-metabolizing enzymes in mice

Suchergebnisse filtern